Ama Gajanayake
Medical · East Stroudsburg, PANPI 1356066625
Payments from drug & device makers
Across 128 payments — averaging $30.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$674
- Neurocrine Biosciences, Inc.$511
- Lilly USA, LLC$320
- Pfizer$276
- Otsuka America Pharmaceutical, Inc.$184
- plus $761 from 13 others
What the payments were for
- Food & beverage$3,921100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $1,195 |
| Teva Pharmaceuticals USA, Inc. | 21 | $674 |
| Neurocrine Biosciences, Inc. | 13 | $511 |
| Lilly USA, LLC | 15 | $320 |
| Pfizer | 12 | $276 |
| Otsuka America Pharmaceutical, Inc. | 9 | $184 |
| UCB, Inc. | 8 | $156 |
| Mallinckrodt Hospital Products Inc. | 1 | $113 |
| SK Life Science, Inc. | 1 | $105 |
| Amneal Pharmaceuticals LLC | 4 | $91 |
| Almatica Pharma LLC | 3 | $63 |
| Biogen | 2 | $43 |
| Eisai Inc. | 2 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Neurelis, Inc. | 1 | $28 |
| Genentech USA, Inc. | 1 | $25 |
| Argenx US, Inc. | 1 | $24 |
| Livanova USA, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,921 in reported general payments places this provider in the 85th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 84 | $152,189 |
| UbrelvyUbrogepant | 55 | $99,014 |
| ZtlidoLidocaine | 79 | $50,024 |
| Emgality PenGalcanezumab-Gnlm | 41 | $29,336 |
| RexultiBrexpiprazole | 15 | $26,669 |
| Diclofenac Sodium | 45 | $14,468 |
| QuliptaAtogepant | 13 | $13,409 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 14 | $9,378 |
| GraliseGabapentin | 19 | $8,358 |
| Lidocaine | 38 | $6,911 |
| Doxepin Hcl | 30 | $6,030 |
| Fluocinonide | 35 | $5,432 |
| Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12) | 57 | $2,619 |
| Diclofenac Sodium ErDiclofenac Sodium | 31 | $2,596 |
| Rivastigmine | 15 | $2,117 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $276 | $152,18984 claims |
| AbbVieUbrelvy, Qulipta | $1,195 | $112,42368 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $184 | $26,66915 claims |
| Almatica Pharma LLCGralise | $63 | $8,35819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,594 medical providers in Pennsylvania.
Other medical in East Stroudsburg
- Jacqueline KernaghanSpringfield$427K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
- Sarah SmithPhiladelphia$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.